Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) | ||||
| Revenue | $ (1,017) | $ 6,485 | $ 1,088 | $ 11,609 |
| Grant income | 749 | 1,055 | 1,717 | 1,947 |
| Total revenue and grant income | (268) | 7,540 | 2,805 | 13,556 |
| Operating Expenses | ||||
| Direct costs | 2,119 | 8,462 | 5,667 | 11,158 |
| Research and development | 19,363 | 18,342 | 37,111 | 37,363 |
| Selling, general and administrative | 8,539 | 6,607 | 16,661 | 14,934 |
| Total operating expenses | 30,021 | 33,411 | 59,439 | 63,455 |
| Operating Loss | (30,289) | (25,871) | (56,634) | (49,899) |
| Nonoperating Income and Expense | ||||
| Interest income | 4,172 | 3,237 | 8,184 | 6,836 |
| Change in fair value of warrant liabilities | 2,250 | (3,216) | 11,891 | 2,663 |
| Interest expense | (9) | (7) | (206) | (15) |
| Other expense | (93) | (151) | (75) | (673) |
| Total nonoperating income and expense | 6,320 | (137) | 19,794 | 8,811 |
| Pretax Loss | (23,969) | (26,008) | (36,840) | (41,088) |
| Income tax expense (income) | (79) | 6 | 5 | 6 |
| Share of net loss (income) of equity method investee | (69) | (676) | 4 | (606) |
| Net Loss Attributable to Common Stockholders | (23,821) | (25,338) | (36,849) | (40,488) |
| Other Comprehensive Income (Loss) | (552) | 13 | (1,958) | 185 |
| Comprehensive Loss Attributable to Common Stockholders | $ (24,373) | $ (25,325) | $ (38,807) | $ (40,303) |
| Basic loss per share | $ (0.11) | $ (0.14) | $ (0.17) | $ (0.22) |
| Diluted loss per share | $ (0.11) | $ (0.14) | $ (0.17) | $ (0.22) |
| Weighted average shares outstanding - Basic | 225,974,899 | 180,343,931 | 221,661,211 | 180,871,314 |
| Weighted average shares outstanding - Diluted | 225,974,899 | 180,343,931 | 221,661,211 | 180,871,314 |
| X | ||||||||||
- Definition The aggregate direct operating costs incurred during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue (reversal) from collaborative arrangement. Includes revenue from contract with customer under Topic 606. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in income from government assistance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after tax of other comprehensive income (loss) attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|